{"id":"https://openalex.org/W2600107601","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2606","title":"Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in advanced solid tumors.","display_name":"Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in advanced solid tumors.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2600107601","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2606","mag":"2600107601"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.2606","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2606","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2606","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034376000","display_name":"Andr\u00e9a Varga","orcid":"https://orcid.org/0000-0002-1314-384X","observed_orcids":["https://orcid.org/0000-0002-1314-384X"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Andrea Varga","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109341340","display_name":"Monica M Mita","orcid":"https://orcid.org/0009-0004-8448-4854","observed_orcids":["https://orcid.org/0009-0004-8448-4854"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monica M. Mita","raw_affiliation_strings":["Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101471773","display_name":"Jennifer J. Wu","orcid":"https://orcid.org/0000-0002-0914-3812","observed_orcids":["https://orcid.org/0000-0002-0914-3812"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer J. Wu","raw_affiliation_strings":["NYU Cancer Institute, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Cancer Institute, New York, NY","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055054082","display_name":"John J. Nemunaitis","orcid":"https://orcid.org/0000-0002-2234-2381","observed_orcids":["https://orcid.org/0000-0002-2234-2381"]},"institutions":[{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John J. Nemunaitis","raw_affiliation_strings":["Mary Crowley Cancer Research Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Center, Dallas, TX","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063511816","display_name":"Timothy Francis Cloughesy","orcid":"https://orcid.org/0000-0002-8656-7483","observed_orcids":["https://orcid.org/0000-0002-8656-7483"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Francis Cloughesy","raw_affiliation_strings":["David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042065032","display_name":"Paul S. Mischel","orcid":"https://orcid.org/0000-0002-4560-2211","observed_orcids":["https://orcid.org/0000-0002-4560-2211"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul S. Mischel","raw_affiliation_strings":["David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028472820","display_name":"Johanna C. Bendell","orcid":"https://orcid.org/0000-0001-9426-5891","observed_orcids":["https://orcid.org/0000-0001-9426-5891"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johanna C. Bendell","raw_affiliation_strings":["Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN","institution_ids":["https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101919113","display_name":"Kent C. Shih","orcid":"https://orcid.org/0000-0002-6718-6116","observed_orcids":["https://orcid.org/0000-0002-6718-6116"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kent C. Shih","raw_affiliation_strings":["SCRI/Tennessee Oncology, PLLC, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCRI/Tennessee Oncology, PLLC, Nashville, TN","institution_ids":["https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052765751","display_name":"Luis G Paz-Ares","orcid":"https://orcid.org/0000-0002-1947-3364","observed_orcids":["https://orcid.org/0000-0002-1947-3364"]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis G. Paz-Ares","raw_affiliation_strings":["Hospital Universitario Virgen del Roc\u00edo, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen del Roc\u00edo, Seville, Spain","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002142386","display_name":"Amit Mahipal","orcid":"https://orcid.org/0000-0002-1111-8333","observed_orcids":["https://orcid.org/0000-0002-1111-8333"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amit Mahipal","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028020706","display_name":"Jean\u2010Pierre Delord","orcid":"https://orcid.org/0000-0001-7305-5561","observed_orcids":["https://orcid.org/0000-0001-7305-5561"]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Pierre Delord","raw_affiliation_strings":["Institut Claudius Regaud, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius Regaud, Toulouse, France","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019481117","display_name":"Robin Kate Kelley","orcid":"https://orcid.org/0000-0002-1984-2430","observed_orcids":["https://orcid.org/0000-0002-1984-2430"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Katie Kelley","raw_affiliation_strings":["Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021624793","display_name":"Jean\u2010Charles Soria","orcid":"https://orcid.org/0000-0001-9597-0701","observed_orcids":["https://orcid.org/0000-0001-9597-0701"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Charles Soria","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088108919","display_name":"Lilly  M. Wong","orcid":"https://orcid.org/0000-0001-7460-8658","observed_orcids":["https://orcid.org/0000-0001-7460-8658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lilly Wong","raw_affiliation_strings":["Celgene Corporation, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109775741","display_name":"Shuichan Xu","orcid":"https://orcid.org/0009-0001-9105-4199","observed_orcids":["https://orcid.org/0009-0001-9105-4199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuichan Xu","raw_affiliation_strings":["Celgene Corporation, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067072967","display_name":"Angela Joubert James","orcid":"https://orcid.org/0009-0003-4509-5787","observed_orcids":["https://orcid.org/0009-0003-4509-5787"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela James","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100655841","display_name":"Xiaoling Wu","orcid":"https://orcid.org/0009-0005-3758-7719","observed_orcids":["https://orcid.org/0009-0005-3758-7719"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoling Wu","raw_affiliation_strings":["Celgene Corporation, Basking Ridge, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Basking Ridge, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111591940","display_name":"Rajesh Chopra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajesh Chopra","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047069710","display_name":"Kristen M. Hege","orcid":"https://orcid.org/0000-0002-9609-5029","observed_orcids":["https://orcid.org/0000-0002-9609-5029"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristen Hege","raw_affiliation_strings":["Celgene Corporation, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, San Francisco, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083373965","display_name":"Pamela N. M\u00fcnster","orcid":"https://orcid.org/0000-0002-2074-0984","observed_orcids":["https://orcid.org/0000-0002-2074-0984","https://orcid.org/0009-0009-4141-2312"]},"institutions":[{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela N. Munster","raw_affiliation_strings":["UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA","institution_ids":["https://openalex.org/I4210167126"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"2606","last_page":"2606"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9480000138282776},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9789999723434448},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.6470000147819519},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8849999904632568},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.47699999809265137},{"id":"https://openalex.org/keywords/p4ebp1","display_name":"p4EBP1","score":0.7110000252723694},{"id":"https://openalex.org/keywords/p-akt","display_name":"pAKT","score":0.8610000014305115},{"id":"https://openalex.org/keywords/glucose-uptake","display_name":"glucose uptake","score":0.593999981880188},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.6209999918937683},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9070588946342468},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6908769011497498},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5861636400222778},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5716115236282349},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5435783863067627},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.49922943115234375},{"id":"https://openalex.org/C2779524853","wikidata":"https://www.wikidata.org/wiki/Q1284347","display_name":"Pneumonitis","level":3,"score":0.4285164475440979},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39729905128479004},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.09907811880111694}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.2606","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.2606","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.2606","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2359879566","https://openalex.org/W1593472362","https://openalex.org/W2809883609","https://openalex.org/W2331775622","https://openalex.org/W2030903519","https://openalex.org/W3169731287","https://openalex.org/W2156438442","https://openalex.org/W4224247842","https://openalex.org/W2907679450","https://openalex.org/W101363650"],"abstract_inverted_index":{"2606":[0],"Background:":[1],"CC-223":[2,16,64,157,291],"is":[3],"an":[4],"ATP-competitive":[5],"inhibitor":[6],"of":[7,22,32,58,81,165,224,229,303,316,331,344],"the":[8,33,106,263,272,310,329],"mTOR":[9,188],"kinase,":[10],"including":[11,46,92],"both":[12],"TORC1":[13,178],"and":[14,51,101,109,138,154,169,180,226,248,270,284,318,325],"TORC2.":[15],"was":[17,65,160,184,194,219,267,292],"selected":[18],"to":[19,60,328],"address":[20],"resistance":[21],"rapamycin":[23],"analogues":[24],"mediated":[25],"by":[26],"TORC2":[27,181],"activation.":[28],"Methods:":[29],"Following":[30],"establishment":[31],"MTD":[34],"(reported":[35],"at":[36,67,216,288,340],"ASCO":[37],"2012),":[38],"subjects":[39,88,166,239,278],"with":[40,167,240,300],"select":[41,334],"advanced,":[42],"refractory":[43],"solid":[44,86],"tumors,":[45],"NSCLC,":[47,107],"HCC,":[48,108,170],"NET,":[49],"GBM":[50,102,110,277,298],"breast":[52,99],"were":[53,130,202,235,286,321],"enrolled":[54,339],"in":[55,72,162,196,205,211,221,237,262,271,294,323],"expansion":[56],"cohorts":[57,111,336],"up":[59],"20":[61],"evaluable":[62,238],"subjects.":[63,231],"dosed":[66],"45":[68],"mg":[69,346],"once":[70],"daily":[71],"28":[73],"day":[74,217],"cycles":[75],"until":[76],"disease":[77],"progression.":[78],"Results:":[79],"As":[80],"09":[82],"January,":[83],"2013,":[84],"101":[85],"tumor":[87,198,233],"have":[89],"been":[90],"treated,":[91],"NSCLC":[93,168,225,241,265],"(26),":[94],"HCC":[95,230,249,273,324],"(25),":[96],"NET":[97,115],"(23),":[98],"(14),":[100],"(13).":[103],"Results":[104],"from":[105],"are":[112,117],"reported":[113,118],"here;":[114],"results":[116,201],"separately.":[119],"The":[120],"most":[121],"common":[122],"(>":[123,208],"20%)":[124],"related":[125,142],"adverse":[126,144],"events":[127,145],"(all":[128],"grades)":[129],"fatigue,":[131],"rash,":[132],"stomatitis,":[133],"hyperglycemia,":[134],"anorexia,":[135],"nausea,":[136],"vomiting":[137],"diarrhea.":[139],"In":[140],"addition,":[141],"serious":[143],"included":[146],"infection":[147],"(1),":[148],"pneumonitis":[149],"(4),":[150],"renal":[151],"insufficiency":[152],"(2)":[153],"pancreatitis":[155],"(2).":[156],"dose":[158,332,343],"reduction":[159],"required":[161],">":[163],"50%":[164],"usually":[171],"during":[172],"cycle":[173],"1":[174,251],"or":[175],"2.":[176],"Exposure-dependent":[177],"(p4EBP1)":[179],"(pAKT)":[182],"inhibition":[183,190],"observed":[185,220,236,322],"across":[186,309],"cohorts.":[187],"pathway":[189],"and/or":[191],"decreased":[192],"proliferation":[193],"demonstrated":[195],"paired":[197],"biopsies,":[199],"but":[200],"inconsistent.":[203],"Reduction":[204],"glucose":[206],"uptake":[207],"25%":[209],"decrease":[210],"SUV)":[212],"on":[213,282],"PET":[214],"imaging":[215],"15":[218,255],"78%":[222],"(14/18)":[223],"69%":[227],"(11/16)":[228],"Partial":[232],"responses":[234],"(1/17;":[242],"confirmed,":[243,252],"treatment":[244,253],"duration":[245,254],"36":[246],"weeks)":[247],"(3/15;":[250],"\u2013":[256],"26":[257],"weeks).":[258],"Disease":[259],"control":[260],"rate":[261],"overall":[264],"cohort":[266],"42%":[268],"(11/26)":[269],"cohort,":[274],"40%":[275],"(10/25).":[276],"underwent":[279],"salvage":[280],"resections":[281],"study":[283],"none":[285],"progression-free":[287],"6":[289],"months.":[290],"present":[293],"all":[295],"(11/11)":[296],"resected":[297],"tumors":[299],"plasma:tumor":[301],"ratios":[302],"16":[304],"-":[305],"77%,":[306],"confirming":[307],"transit":[308],"blood-brain":[311],"barrier.":[312],"Conclusions:":[313],"Encouraging":[314],"signals":[315],"biomarker":[317],"clinical":[319],"activity":[320],"NSCLC.":[326],"Due":[327],"frequency":[330],"reductions,":[333],"additional":[335],"will":[337],"be":[338],"a":[341],"starting":[342],"30":[345],"QD.":[347],"Clinical":[348],"trial":[349],"information:":[350],"NCT01177397.":[351]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2025-10-10T00:00:00"}